Featured,Spotlight Stock,Trends & Articles Bright Minds Shares Starts Trading on OTCQB Venture Market By Dennis Mutua May 18, 2021 Biopharmaceutical company specializing on developing second generation therapies to better lives of patients with severe brain injuries Bright Minds Biosciences Inc. (CNSX: DRUG) (OTCQB:BMBIF) announced that its shares will begin ...
Featured,Trends & Articles Rapper Lil Xan Supports Legalization of Psychedelics to Treat Depression By Dennis Mutua May 17, 2021 Mexican-America rapper Lil Xan also known as Diego is supporting decriminalization of psychedelics to assist in treating patients suffering from various mental illnesses including post-traumatic stress disorder ad depression among...
Psychedelic Stocks,Shroom News BetterLife Pharma Closes a Non-Brokered Private Placement By Dennis Mutua May 17, 2021 Life Sciences company specializing on developing second generation psychedelics compounds for treatment of mental disorders BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) announced having closed a non-brokered private placement...
Shroom News Silo Pharma Submits Study of Using Psilocybin to Treat Parkinson’s Disease to be Reviewed by Ethics Board By Dennis Mutua May 14, 2021 Developmental stage biopharmaceutical company specializing on integrating traditional therapeutics with psychedelics to treat various mental conditions Silo Pharma Inc. (OTCMKTS: SILO) announced having submitted a study in which p...
Featured,Spotlight Stock,Trends & Articles World Boxing Council Partners With Wesana to Explore Psychedelics as Potential Treatment For Traumatic Brain Injury By Dennis Mutua May 14, 2021 The World Boxing Council (WBC) says it has entered into a partnership with life sciences company focusing on using psychedelics therapies to treat brain injuries Wesana Health Holding Inc. (CSE: WESA) to study how psychedelics can...
Featured,Shroom News,Spotlight Stock PsyBio files For Provisional U.S Patent for Production of Psilocybin By Dennis Mutua May 13, 2021 Biotechnology company specializing in developing next generation biosynthetic psychoactive compounds to teat mental illnesses PsyBio Therapeutics Corp. (CVE: PSYB) (OTCPINK: PSYBF) announced having filed for provisional patent wit...
Psychedelic Stocks,Trends & Articles IntelGenx Receives Shareholders Node For Atai Investment By Dennis Mutua May 13, 2021 Drug delivery pharmaceutical company focusing on development of novel oral thin film technology IntelGenx Technologies Corp. (TSV: IGX) (OTCQB: IGXT) received shareholders’ approval for the company to invest in clinical stage bi...
Featured,Spotlight Stock,Trends & Articles Psychedelics Investment Potential Exceed That of Cannabis by Far Says Kevin O’Leary By Dennis Mutua May 12, 2021 Canadian business man, politician and television personality Kevin O’Leary believes the psychedelics industry bears far much more investment potential compared to the cannabis industry. O’leaty made the sentiments on 11 May du...